PremiumThe FlyCERo Therapeutics Holdings Inc trading halted, volatility trading pause CERo Therapeutics Gains FDA Orphan Drug Designation Cero Therapeutics announces FDA ODD granted to CER-1236 PremiumThe FlyCero Therapeutics announces 1-for-20 reverse stock split Upcoming Stock Splits This Week (June 9 to June 13) – Stay Invested CERo Therapeutics Completes Series D Stock Issuance PremiumThe FlyCero Therapeutics doses first patient with CER-1236 in Phase 1 trial Cero Therapeutics downgraded to Hold from Buy at D. Boral Capital CERo Therapeutics Approves Key Proposals at Annual Meeting